Pieris Pharmaceuticals Inc. (PIRS) skyrocketing in premarket. Here’s the update

Pieris Pharma Inc. (NASDAQ: PIRS) stock surged by 23.45% at last close whereas the PIRS stock price soared by 15.79% in the pre-market trading session. Pieris is a clinical-stage biotechnology firm that combines top protein engineering skills with a comprehensive understanding of disease molecular drivers to create medications that drive local biology and improve patient […]

Market Globalist
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.